Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments.
Citation: JACC Heart Failure. 7(3):225-227, 2019 03.PMID: 30819378Institution: MedStar Heart & Vascular InstitutenaForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: *Breast Neoplasms | *Heart Failure | Cardiotoxicity | Chemotherapy, Adjuvant | Heart | Humans | TrastuzumabYear: 2019ISSN:- 2213-1779
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 30819378 | Available | 30819378 |
English